Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients
Open Access
- 7 January 2021
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 22 (1) , 1-9
Abstract
Background: For antibiotic treatment of Acute exacerbations of COPD (AECOPD) the National guidelines in Denmark recommend either first choice amoxicillin 750 mg TID (AMX) or amoxicillin with clavulanic acid 500 mg/125 mg TID (AMC). Addition of clavulanic acid offers a broader spectrum; opposite, AMX alone in a higher dose may offer more time above MIC. The aim of this study was to determine which of these regimens is associated with better outcome. Methods: The Danish Registry of COPD (DrCOPD), a nationwide outpatient COPD registry, was crosslinked with medication data and hospital contacts. The first prescription of AMX or AMC after inclusion in DrCOPD was used as exposure variable. Adjusted Cox proportional hazards models were used to analyze the risk of hospitalization or death (combined) within 30 days and other endpoints. Results: For the first treatment of AECOPD 12,915 received AMX, and 30,721 patients received AMC. AMX was associated with a decreased risk of pneumonia hospitalization or death (aHR 0.6, 95% CI 0.5–0.7; p < 0.0001) compared to AMC. Conclusion: In AECOPD, empirically adding clavulanic acid to amoxicillin is not associated with a better outcome; it seems safe for these patients to be treated with amoxicillin alone.Keywords
This publication has 26 references indexed in Scilit:
- Antibiotics for exacerbations of chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2012
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed PrescriptionsClinical Epidemiology, 2012
- Relation Between Amoxicillin Concentration in Sputum of COPD Patients and Length of HospitalizationCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2011
- Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic reviewRespiratory Research, 2007
- Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanateDiagnostic Microbiology and Infectious Disease, 2007
- The Alexander Project: the benefits from a decade of surveillanceJournal of Antimicrobial Chemotherapy, 2005
- New Formulations of Amoxicillin/Clavulanic AcidClinical Pharmacokinetics, 2005
- The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agentsJournal of Antimicrobial Chemotherapy, 2003
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983